Mini Review - Journal of Diabetology (2024) Volume 8, Issue 4

From Metformin to Insulin: Exploring the Range of Anti-Diabetic Treatments

p> Carlos Joseph ^*

Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

*Corresponding Author:

Ghina Ghazeeri
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy
E-mail: joseph.c0981@unifi.

Received: 27-Jun-2024, Manuscript No. . AADY-24-143997; Editor assigned: 29-Jun-2024, PreQC No. . AADY-24-143997 (PQ); Reviewed:13-Jul-2024, QC No. . AADY-24-143997; Revised:15-Jul-2024, Manuscript No. . AADY-24-143997 (R); Published: 22-Jul-2024, DOI:10.35841/aady -8.5.217

Citation: Joseph C. From metformin to insulin: Exploring the range of anti-diabetic treatments, J Diabetol. 2024; 8(4):217

Abstract

Introduction

Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels, affects millions of people worldwide. Effective management of diabetes is crucial in preventing complications and maintaining a good quality of life. The spectrum of anti-diabetic treatments has evolved significantly over the years, offering a wide range of options to help individuals with diabetes control their blood glucose levels. In this article, we will explore the various classes of anti-diabetic drugs, from the commonly prescribed Metformin to insulin therapy, providing insight into their mechanisms of action and when they are typically recommended [1,2].

Metformin: The first-line therapy

Metformin, a biguanide medication, has long been the first-line therapy for type 2 diabetes. It works by decreasing the amount of glucose produced by the liver and improving the body's sensitivity to insulin, making it easier for cells to absorb glucose. Metformin is typically the initial choice because of its proven efficacy, low risk of hypoglycemia (dangerously low blood sugar), and minimal side effects [3,4].

Sulfonylureas and meglitinides: stimulating insulin release

Sulfonylureas (e.g., glipizide, glyburide) and meglitinides (e.g., repaglinide) are oral medications that work by stimulating the pancreas to release more insulin. They are often used when Metformin alone does not provide adequate blood sugar control. While effective, they carry a higher risk of hypoglycemia and may lead to weight gain [5, 6].

Thiazolidinedione: enhancing insulin sensitivity

Thiazolidinediones (e.g., pioglitazone) improve insulin sensitivity in the body's cells and reduce glucose production in the liver. They are suitable for some individuals, but their use may be limited due to potential side effects, such as weight gain and an increased risk of heart problems [7].

1. Alpha-glucosidase inhibitors: slowing carbohydrate digestion

Alpha-glucosidase inhibitors (e.g., acarbose) slow down the digestion of carbohydrates in the small intestine, which helps prevent rapid spikes in blood sugar levels after meals. They are often used in combination with other medications and can be helpful for post-meal glucose control.

2. Incretin-Based Therapies: Enhancing Insulin Release and Reducing Glucose Production

Incretin-based therapies include GLP-1 receptor agonists (e.g., exenatide, liraglutide) and DPP-4 inhibitors (e.g., sitagliptin, saxagliptin). They work by increasing insulin secretion and reducing the production of glucagon, a hormone that raises blood sugar. These medications are available in injectable and oral forms and are well-tolerated by many patients.

3. SGLT-2 Inhibitors: Promoting glucose excretion

SGLT-2 inhibitors (e.g., empagliflozin, canagliflozin) target the kidneys, reducing glucose reabsorption and increasing its excretion through urine. They have shown benefits in both blood sugar control and cardiovascular health. However, they may be associated with an increased risk of urinary tract infections and genital fungal infections .

4. Insulin therapy: The last resort

For individuals with type 1 diabetes and some with type 2 diabetes, insulin therapy becomes necessary. Insulin is essential for regulating blood sugar levels, and it is administered via injections or insulin pumps. Different types of insulin (e.g., rapid-acting, long-acting) are used to mimic the body's natural insulin production and address specific needs, such as mealtime spikes or overnight control [8-10].

Conclusion

Navigating the spectrum of anti-diabetic treatments can be complex, but it allows healthcare professionals to tailor therapy to each individual's needs. Metformin remains the cornerstone of treatment for many, while other medications and insulin therapy are introduced as required. Effective diabetes management involves a holistic approach, including diet, exercise, regular monitoring, and medication adherence. Always consult with a healthcare provider to determine the most suitable anti-diabetic treatment plan for your specific situation, keeping in mind that ongoing research may lead to new and even more effective therapies in the future.

References

Gambini J, Inglés M, Olaso Get al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015.

Indexed at, Google Scholar, Cross Ref

Koushki M, Amiri?Dashatan N, Ahmadi N, et al. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473-90.

Indexed at, Google Scholar, Cross Ref

Pignet AL, Schellnegger M, Hecker A, et al. Resveratrol-induced signal transduction in wound healing. Int J Mol Sci. 2021;22(23):12614.

Indexed at, Google Scholar, Cross Ref

Kumari A, Raina N, Wahi A, et al. Wound-Healing Effects of Curcumin and Its Nanoformulations: A Comprehensive Review. Pharmaceutics. 2022;14(11):2288.

Indexed at, Google Scholar, Cross Ref

Prasad S, Aggarwal BB. Turmeric, the golden spice. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011.

Google Scholar

Salehi B, Fokou PV, Sharifi-Rad M, et al. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals. 2019;12(1):11.

Indexed at, Google Scholar, Cross Ref

Sun R, Liu C, Liu J, et al. Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds. Scientific Reports. 2023;13(1):132.

Indexed at, Google Scholar, Cross Ref

Diniz LR, Calado LL, Duarte AB, et al. Centella asiatica and Its Metabolite Asiatic Acid: Wound Healing Effects and Therapeutic Potential. Metabolites. 2023;13(2):276.

Indexed at, Google Scholar, Cross Ref

Morissette M, Litim N, Di Paolo T. Natural phytoestrogens: A class of promising neuroprotective agents for Parkinson disease. InDiscovery and Development of Neuroprotective Agents from Natural Products 2018 (pp. 9-61). Elsevier.

Indexed at, Google Scholar, Cross Ref

Lan X, Wang W, Li Q, et al. The natural flavonoid pinocembrin: molecular targets and potential therapeutic applications. Mol Neurobiol. 2016;53:1794-801.